Na Li1, Pengfei Liu2, Lianwen Wang1, Jingbo Liu1, Xiao Yuan1, Wei Meng3, Yan Dong3, Boqing Li4. 1. Department of Nuclear Medicine, The Affiliated Hospital of Binzhou Medical University Binzhou 256600. 2. Department of Neurosurgery, The Affiliated Hospital of Binzhou Medical University Binzhou 256600. 3. Department of Clinical Laboratory, The Affiliated Hospital of Binzhou Medical University Binzhou 256600. 4. Department of Pathogeny Biology, Binzhou Medical University Yantai 264003.
Abstract
BACKGROUND: Intracellular pathogen resistance 1 (Ipr1) has been found in macrophages and plays a pivotal role in fighting against Mycobacterium tuberculosis (Mtb) infection. This study is designed to evaluate the effect of Iprl on the expression of macrophage genes related to the anti-infection of Mtb. Design or methods: In the experimental and control groups, the macrophages were infected with Mycobacterium H37Ra, and then the related immune genes between two groups were detected using microarray assay. Real-time quantitative PCR was applied to detect the differences in the expression of three up-regulated genes detected by microarray assay and to verify the reliability of microarray assay. RESULTS: The expression of Iprl up-regulated 11 genes related to macrophage anti-immunity involved TLRs signaling pathway including TLR2 and TLR4, Irak1, Traf7, Ifngr1 and Tnfrsfla. No significant difference was found in terms of the molecular expression involved in regulation of the adaptive immune response, such as IL-1 and IL-12. The results of real-time PCR were consistent with the findings of microarray assay. CONCLUSIONS: The expression of Iprl gene probably promotes macrophage activity and enhances the ability of macrophages to fight against Mtb infection. The underlying mechanism may be achieved by up-regulating the expression levels of innate immunity genes, especially TLR2/TLR4 and signal transduction molecules, which is determined using microarray assay. All these findings offer the basis for subsequent study of the mechanisms of Ipr1 gene in host innate immunity against Mtb infection.
BACKGROUND: Intracellular pathogen resistance 1 (Ipr1) has been found in macrophages and plays a pivotal role in fighting against Mycobacteriumtuberculosis (Mtb) infection. This study is designed to evaluate the effect of Iprl on the expression of macrophage genes related to the anti-infection of Mtb. Design or methods: In the experimental and control groups, the macrophages were infected with MycobacteriumH37Ra, and then the related immune genes between two groups were detected using microarray assay. Real-time quantitative PCR was applied to detect the differences in the expression of three up-regulated genes detected by microarray assay and to verify the reliability of microarray assay. RESULTS: The expression of Iprl up-regulated 11 genes related to macrophage anti-immunity involved TLRs signaling pathway including TLR2 and TLR4, Irak1, Traf7, Ifngr1 and Tnfrsfla. No significant difference was found in terms of the molecular expression involved in regulation of the adaptive immune response, such as IL-1 and IL-12. The results of real-time PCR were consistent with the findings of microarray assay. CONCLUSIONS: The expression of Iprl gene probably promotes macrophage activity and enhances the ability of macrophages to fight against Mtb infection. The underlying mechanism may be achieved by up-regulating the expression levels of innate immunity genes, especially TLR2/TLR4 and signal transduction molecules, which is determined using microarray assay. All these findings offer the basis for subsequent study of the mechanisms of Ipr1 gene in host innate immunity against Mtb infection.
Authors: Hui Pan; Bo-Shiun Yan; Mauricio Rojas; Yuriy V Shebzukhov; Hongwei Zhou; Lester Kobzik; Darren E Higgins; Mark J Daly; Barry R Bloom; Igor Kramnik Journal: Nature Date: 2005-04-07 Impact factor: 49.962
Authors: Mario Raviglione; Ben Marais; Katherine Floyd; Knut Lönnroth; Haileyesus Getahun; Giovanni B Migliori; Anthony D Harries; Paul Nunn; Christian Lienhardt; Steve Graham; Jeremiah Chakaya; Karin Weyer; Stewart Cole; Stefan H E Kaufmann; Alimuddin Zumla Journal: Lancet Date: 2012-05-19 Impact factor: 79.321
Authors: X N He; F Su; Z Z Lou; W Z Jia; Y L Song; H Y Chang; Y H Wu; J Lan; X Y He; Y Zhang Journal: Scand J Immunol Date: 2011-11 Impact factor: 3.487
Authors: Cecile M Fremond; Vladimir Yeremeev; Delphine M Nicolle; Muazzam Jacobs; Valerie F Quesniaux; Bernhard Ryffel Journal: J Clin Invest Date: 2004-12 Impact factor: 14.808
Authors: Carl G Feng; Mallika Kaviratne; Antonio Gigliotti Rothfuchs; Allen Cheever; Sara Hieny; Howard A Young; Thomas A Wynn; Alan Sher Journal: J Immunol Date: 2006-11-15 Impact factor: 5.422